Munafa Stock Market Course + Intraday & FNO calls 
Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Neurocrine Biosciences (NBIX)
Technical Analysis Report for USA stock NBIX Neurocrine Biosciences. Dated: 07 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NBIX Neurocrine Biosciences then click here. or read Experts views on Neurocrine Biosciences or Forecast & share price targets of Neurocrine Biosciences
Neurocrine Biosciences Opened at 161.53 and Closed at: 163.41, which is 2.21% of previous session's close. It moved within a range of 159.68 and 164.76
The session was a Bullish session with an average volume of 971000, which is 21.31% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 2 days back on short term averages
A Golden cross was found 9 days back on short term averages
Support for tomorrow is 161.55 and resistance for tomorrow is 166.63
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 160.47, 157.54 resistance for tomorrow's hourly charts is 165.55, 167.7
10 Day SMA for Neurocrine Biosciences (NBIX) is 170.93 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Neurocrine Biosciences (NBIX) is 172.31 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Neurocrine Biosciences (NBIX) is 168.51 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 153.6 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Neurocrine Biosciences is 146.75 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Neurocrine Biosciences is at 172.31 and 200 DMA is at 146.75, while 50 DMA and 100 DMA are at 168.51 and 153.6 respectively
Neurocrine Biosciences (NBIX) moving average of 20 SMA is at 172.31 and 20 EMA is at 170.16
| Date | Closing Price | 20 SMA | 20 EMA |
| 07 Fri Aug | 163.41 | 172.31 | 170.16 |
| 06 Thu Aug | 159.80 | 172.85 | 170.87 |
| 05 Wed Aug | 161.50 | 173.72 | 172.04 |
| 04 Tue Aug | 166.06 | 174.67 | 173.15 |
| 03 Mon Aug | 166.23 | 175.27 | 173.9 |
| 31 Fri Jul | 166.80 | 175.83 | 174.71 |
Neurocrine Biosciences (NBIX) moving average of 50 SMA is at 168.51 and 50 EMA is at 166.59
| Date | Closing Price | 50 SMA | 50 EMA |
| 07 Fri Aug | 163.41 | 168.51 | 166.59 |
| 06 Thu Aug | 159.80 | 168.37 | 166.72 |
| 05 Wed Aug | 161.50 | 168.29 | 167 |
| 04 Tue Aug | 166.06 | 168.18 | 167.22 |
| 03 Mon Aug | 166.23 | 167.99 | 167.27 |
| 31 Fri Jul | 166.80 | 167.77 | 167.31 |
Neurocrine Biosciences (NBIX) moving average of 100 SMA is at 153.6 and 100 EMA is at 158.56
| Date | Closing Price | 100 SMA | 100 EMA |
| 07 Fri Aug | 163.41 | 153.6 | 158.56 |
| 06 Thu Aug | 159.80 | 153.27 | 158.46 |
| 05 Wed Aug | 161.50 | 152.97 | 158.43 |
| 04 Tue Aug | 166.06 | 152.66 | 158.37 |
| 03 Mon Aug | 166.23 | 152.27 | 158.21 |
| 31 Fri Jul | 166.80 | 151.91 | 158.05 |
Neurocrine Biosciences (NBIX) moving average of 200 SMA is at 146.75 and 200 EMA is at 149.24
| Date | Closing Price | 200 SMA | 200 EMA |
| 07 Fri Aug | 163.41 | 146.75 | 149.24 |
| 06 Thu Aug | 159.80 | 146.65 | 149.1 |
| 05 Wed Aug | 161.50 | 146.56 | 148.99 |
| 04 Tue Aug | 166.06 | 146.45 | 148.86 |
| 03 Mon Aug | 166.23 | 146.31 | 148.69 |
| 31 Fri Jul | 166.80 | 146.16 | 148.51 |
Johnson Johnson has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Johnson Johnson, about 7.14% more returns!
Iqvia Holdings has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Iqvia Holdings, about 19.87% more returns!
Neurocrine Biosciences has performed better than Davita Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Xenon Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Utah Medical has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Utah Medical, about 8.8% more returns!
United Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in United Therapeutics, about 7.33% more returns!
Scholar Rock has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Scholar Rock, about 3.42% more returns!
Uniqure N has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Uniqure N, about 16.82% more returns!
Neurocrine Biosciences has performed better than Intellia Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Medpace Holdings has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Medpace Holdings, about 15.18% more returns!
Liquidia Technologies has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Liquidia Technologies, about 22.97% more returns!
Kiniksa Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 27.74% more returns!
Neurocrine Biosciences has performed better than Innoviva Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Denali Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Denali Therapeutics, about 14.64% more returns!
Biolife Solutions has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Biolife Solutions, about 26% more returns!
Biogen Inc has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Biogen Inc, about 13.35% more returns!
Neurocrine Biosciences has performed better than Alnylam Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Aldeyra Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences Technical analysis of indicators
Price action analysis of Neurocrine Biosciences (NBIX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Neurocrine Biosciences in short term and the sell signal is strong.
Neurocrine Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Neurocrine Biosciences in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Neurocrine Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 170.38 and Neurocrine Biosciences NBIX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Neurocrine Biosciences NBIX stock. Volume based technical analysis of Neurocrine Biosciences NBIX stock is negative.
Neurocrine Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NBIX Neurocrine Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NBIX Experts View which covers a lot of information including buying and selling signals
NBIX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Neurocrine Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
